Discover Great Companies Discover Great Clients
Popularity  4913   |   Followers  2   |   Likes  1 Claim this company

Gene therapy developer

No.116 Qiantang District Popularity Ranking Hangzhou Zhejiang No.5 Xi Bao Zhi Liao No.6 Ji Yin Zhi Liao No.8 Pharmaceutical CRO No.9 Pharmaceutical Contracts R&D No.9 CDMO No.11 CRO No.12 Yi Yao Xin Yao No.18 Xin Yao R&D No.19 Innovative Drugs No.24 Packaging Materials No.25 Pharmaceutical R&D No.29 Sheng Ming Ke Xue 专精特新小巨人企业 省级高新技术企业 科技型中小企业 省科技型中小企业 省级创新型中小企业 高新技术企业
More

Company Overview

  • Nature: Private Enterprise Size: 50-99 employees Founded: 11年
  • Industry: Pharmaceuticals/Bioengineering
  • Full name: Kanglin Biotechnology (Hangzhou) Co., Ltd.。

Development Stage

  • Stage: A+轮。
  • Ranking: Ranked #5 in Hangzhou Xi Bao Zhi Liao Company by popularity Ranked #6 in Hangzhou Ji Yin Zhi Liao Company by popularity Ranked #8 in Hangzhou Pharmaceutical CRO Company by popularity Ranked #9 in Hangzhou Pharmaceutical Contracts R&D Company by popularity
  • Honors: 专精特新小巨人企业 省级高新技术企业 According to algorithm
  • Salary: 63.7% of positions earn 8-15K, In 2026 vs last yeargrew by 28%.。Master's salary: ¥17.0K, Doctorate salary: ¥17.5K.
  • R&D: "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 33.3%, "Medical & Health/Beauty & Healthcare": 15.2%, "Electrical/Energy/Power": 9.1%。
  • Recruiting: In 2026 vs 2025grew by 25%. Demand for highly educated talent: Doctorate: 1.
  • Requirement: Education: 本科 leads with 75.8%. Experience: 1-3年 leads with 57.6%.
  • Region: Distributed across 2 regions, 杭州: 75.8%, 广州: 24.2%.

About the Company

[Summary] Gene therapy developer

Kanglin Biotechnology (Hangzhou) Co., Ltd. was founded in August 2015 with a registered capital of RMB 50 million, initially located in the High-tech Incubator of Hangzhou Economic and Technological Development Zone. To accelerate its growth, the company relocated to Hangzhou Eastern Medical Port Town in October 2017. Its R&D center now covers more than 1,700 square meters, including a GMP workshop of over 400 square meters built to CFDA standards.
Kanglin Biotechnology has assembled an outstanding R&D and management team. The expert team is composed of professors from renowned American research institutions and senior corporate executives, all of whom have led multiple large-scale research projects of the U.S. National Institutes of Health (NIH) and possess extensive R&D and management experience, providing strong support for the company's technology development and product upgrading. Two senior executives of the company were respectively selected for the 2017 Hangzhou "115" Plan for Introducing Overseas (Foreign) Expertise and the second batch of Hangzhou's "521" Global Talent Recruitment Plan. Among the team, 19% hold doctoral degrees, 50% hold master's degrees, and 31% hold bachelor's degrees, with a well-established research, quality inspection, and administrative workforce.
Kanglin Biotechnology focuses on the R&D of gene therapy and cell therapy technologies. Its current project, "Functional Cure of AIDS," has received support from the National 13th Five-Year Plan Major Science and Technology Project "Prevention and Treatment of Major Infectious Diseases such as AIDS and Viral Hepatitis." Meanwhile, the company has leading technologies in lentiviral vector preparation, T-cell transduction, and T-cell gene editing, and is particularly skilled in large-scale clinical-grade lentiviral vector preparation. Kanglin Biotechnology's lentivirus production platform is the cornerstone of its development; the company has invested substantial manpower and resources to develop a clinical-grade, high-purity lentivirus production process, with technology reaching a leading level. Adhering to a strategy of parallel development of new drug R&D and CRO, the company both independently develops gene therapy technologies for the functional cure of AIDS and provides clinical-grade lentivirus packaging services to peers engaged in gene therapy and cell therapy.
Guided by the vision of "Conquering Intractable Diseases, Saving Lives," Kanglin Biotechnology will continue to forge ahead on the path of gene therapy and pursue excellence!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Kanglin Biotechnology Financing History (6 rounds)

Manage
A+轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 中国太平

Kanglin Biotechnology How Fast Is Hiring Growing? (14 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 50%
  • 2024: Down 65%
  • 2023: Up 1433%
  • 2022: Down 89%
Kanglin Biotechnology Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Kanglin Biotechnology Campus Recruitment & Advanced Degree Talent Demand
Graduates 1 Doctorate 1
Note: How fast is hiring at Kanglin Biotechnology (Hangzhou) Co., Ltd. growing? Kanglin Biotechnology2026: 30 openings (up 25%), 2025: 24 openings (up 50%), 2024: 16 openings (down 65%), 2023: 46 openings (up 1433%), 2022: 3 openings (down 89%), 2021: 28 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Kanglin Biotechnology R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Kanglin Biotechnology (Hangzhou) Co., Ltd.? Based on an analysis of Kanglin Biotechnology's job postings over the past year, "Biology/Pharmaceutical/Chemical/Environmental Protection" demand: 33.3%, "Medical & Health/Beauty & Healthcare": 15.2%, "Electrical/Energy/Power": 9.1%, "Other (R&D and Technical)": 6.1%. For reference only.

Kanglin Biotechnology — What Are the Salaries Like? (33 records)

Manage
salary range: 6K - 30K, 63.7% of roles pay ¥8-15K
Note: salary statistics are based on 33 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Kanglin Biotechnology (Hangzhou) Co., Ltd.?Kanglin Biotechnology63.7% of positions earn 8-15K, Fresh graduate salary: ¥17.5K。Hangzhou salary ranking: #2797,Factory Production average salary ¥9.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of Kanglin Biotechnology

(More)
Are salaries high at Kanglin Biotechnology (Hangzhou) Co., Ltd.? We provide: QA, 知识产权, ra, 临床, 产权专员, 协调专员, 暖通, Production Technician, 研发助理, Project Manager, crc, QC, Utilities Engineer, 医学经理, 协调员, 申报专员, Electrical Engineer, 研发经理, Automation Engineer, 药学. Click to view detailed salary analysis by job.

Kanglin Biotechnology honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Job Category

  • Factory Production
    42.4% of total 42.4%
  • Biology/Pharmaceutical/Chemical/Environmental Protection
    33.3% of total 33.3%
  • Legal
    18.2% of total 18.2%
  • Quality Management
    18.2% of total 18.2%

Education

  • 本科
    75.8% of total 75.8%
  • 大专
    15.2% of total 15.2%
  • 硕士
    6.1% of total 6.1%
  • 博士
    3% of total 3%

Experience

  • 1-3年
    57.6% of total 57.6%
  • 3-5年
    30.3% of total 30.3%
  • 不限
    6.1% of total 6.1%
  • 应届生
    3% of total 3%
View Detailed Analysis

What does Kanglin Biotechnology (Hangzhou) Co., Ltd. require? Who is Kanglin Biotechnology hiring? Kanglin Biotechnology recruitment: Factory Production占比最多占42.4%,其次是Biology/Pharmaceutical/Chemical/Environmental Protection占33.3%. What education can get in at Kanglin Biotechnology? 本科占比最多占75.8%,其次是大专占15.2%. High education required at Kanglin Biotechnology? 硕士占6.1%,博士占3%. Work experience required at Kanglin Biotechnology? 1-3年占比最多占57.6%,其次是3-5年占30.3%. Where are the job locations at Kanglin Biotechnology? 杭州占比最多占75.8%,其次是广州占24.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 7,117.3111万(元)
Legal Representative: 吴昊泉
Date Established:
Credit Code: 91330101328187155W
Registered Address: 浙江省杭州市钱塘区下沙街道福城路291号4-301室

Partners & Suppliers

康霖生物委托宜明细胞提供慢病毒载体生产服务 Source
供应商 CRO/CDMO

People who follow Kanglin Biotechnology also follow

Kanglin Biotechnology Competitors (Similar Companies)

“定制化新型给药装置解决方案供应商”
“Mainly engaged in the production and sales of antibiotics, traditional”
“Home furnishing brand operator”
生物科技/生物工程 生物制剂 药物研发 生物医药
企业服务 专利代理 税务筹划 科技项目申报
“A provincial high-tech enterprise specializing in the development, pro”
节能减排 碳减排 低碳环保 循环经济
“A high-tech enterprise dedicated to the research, development, and ind”
医药 生物医药 新药研发 抗体药
“A modern comprehensive pharmaceutical enterprise integrating R&D, prod”
“Committed to building an ecosystem for 3D digitalization and 3D printi”
医药 化工/化学原料 多肽 辅助生殖
制药/药业 药物研发 新药研发 CRO
临床试验 CDMO 医疗科技 医疗器械
大健康 检测机构 第三方检测 液质联用

Discover Great Companies, Discover Great Clients

杭州公司名录 杭州“Qiantang District”公司名录 杭州“生物科技/生物工程”公司名录 杭州“医药”公司名录 杭州“新药研发”公司名录 杭州“CRO”公司名录 杭州“细胞治疗”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates